Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | GAA | P10253 | 1/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.78 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.78 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.78 |
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.55 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | AHR | P35869 | 3/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.46 |
| ▸ | F7 | P08709 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | F3 | P13726 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | GUSB | P08236 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29440252 | 0.88 | USP2 (1.00) | USP2GAAALOX15RAD51NPSR1 | |
| SCHEMBL50566 | 0.88 | USP2 (1.00) | USP2GAAALOX15RAD51NPSR1 | |
| Water SCHEMBL28220544 | 0.86 | USP2 (0.95) | USP2GAAALOX15RAD51NPSR1 | |
| Bromide SCHEMBL6029763 | 0.86 | USP2 (0.95) | USP2GAAALOX15RAD51NPSR1 | |
| Hydrochloric Acid SCHEMBL4718421 | 0.86 | USP2 (0.95) | USP2GAAALOX15RAD51NPSR1 | |
| Acetic Acid SCHEMBL122895 | 0.85 | USP2 (0.78) | USP2GAAALOX15RAD51NPSR1 | |
| Tert-Butyl Formate SCHEMBL27623661 | 0.84 | USP2 (0.64) | USP2GAAALOX15RAD51NPSR1 | |
| Ethoxycarbonyl Group SCHEMBL27597884 | 0.82 | GAA (0.62) | USP2GAAALOX15RAD51NPSR1 | |
| SCHEMBL5447196 | 0.81 | TYR (0.84) | USP2GAAALOX15RAD51NPSR1 | |
| SCHEMBL4542260 | 0.81 | USP2 (0.70) | USP2GAAALOX15RAD51NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473199-A1 | ISOTOPICALLY LABELED NEUROCHEMICAL AGENTS AND USES THEREOF FOR DIAGNOSING CONDITIONS AND DISORDERS | Brain Watch Ltd. (IL) | 2012-07-11 | — | — | EP | claimed |
| US-20120156139-A1 | ISOTOPICALLY LABELED NEUROCHEMICAL AGENTS AND USES THEROF FOR DIAGNOSING CONDITIONS AND DISORDERS | BRAIN WATCH LTD. (IL) | 2012-06-21 | — | — | US | claimed |
| WO-2011024156-A1 | ISOTOPICALLY LABELED NEUROCHEMICAL AGENTS AND USES THEREOF FOR DIAGNOSING CONDITIONS AND DISORDERS | BRAIN WATCH LTD. (IL) | 2011-03-03 | — | — | WO | claimed |
| US-20080287774-A1 | Magnetic Resonance Imaging and Spectroscopy Means and Methods Thereof | BRAIN WATCH LTD. (IL) | 2008-11-20 | — | — | US | claimed |
| EP-4627069-A1 | FOOD AND PHARMACEUTICAL COMPOSITION FOR DETOXIFYING ENDOGENOUS ALDEHYDES | Picoentech Co., Ltd. (KR) | 2025-10-08 | — | — | EP | disclosed |
| WO-2024117698-A1 | FOOD AND PHARMACEUTICAL COMPOSITION FOR DETOXIFYING ENDOGENOUS ALDEHYDES | PICOENTECH Co., LTD. (KR) | 2024-06-06 | — | — | WO | disclosed |
| US-20240182915-A1 | FOOD AND PHARMACEUTICAL COMPOSITION FOR DETOXIFYING ENDOGENOUS ALDEHYDES | PICOENTECH Co., LTD. (KR) | 2024-06-06 | — | — | US | disclosed |
| US-20170240652-A1 | ANTIBODIES AGAINST SEROTONIN, TRYPTOPHAN AND KYNURENINE METABOLITES AND USES THEREOF | NESTEC S.A. (CH) | 2017-08-24 | — | — | US | disclosed |
| US-9673030-B2 | Computer readable storage mediums, methods and systems for normalizing chemical profiles in biological or medical samples detected by mass spectrometry | EMORY UNIVERSITY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9364474-B2 | Method for treatment of neurologic dysfunction | MEDDEV INC. (US) | 2016-06-14 | — | — | US | disclosed |
| EP-3004068-A2 | PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS | Nestec S.A. (CH) | 2016-04-13 | — | — | EP | disclosed |
| US-20140018382-A1 | Method for treament of neurologic dysfunction | MedDEV, Inc. (US) | 2014-01-16 | — | — | US | disclosed |
| US-20090029993-A1 | METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN | LEXICON PHARMACEUTICALS, INC. | 2009-01-29 | — | — | US | disclosed |
| US-20090005381-A1 | METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS | LEXICON PHARMACEUTICALS, INC. | 2009-01-01 | — | — | US | disclosed |
| US-20090005382-A1 | METHODS OF USING AND COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS | TERSERA THERAPEUTICS LLC | 2009-01-01 | — | — | US | disclosed |
| WO-2009002964-A1 | METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS | LEXICON PHARMACEUTICALS, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| WO-2009002970-A1 | COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS | LEXICON PHARMACEUTICALS, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| US-20080287774-A1 | Magnetic Resonance Imaging and Spectroscopy Means and Methods Thereof | BRAIN WATCH LTD. (IL) | 2008-11-20 | — | — | US | disclosed |
| EP-1948248-A2 | MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY MEANS AND METHODS THEREOF | Katz-Brull, Rachel (IL) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007052274-A2 | MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY MEANS AND METHODS THEREOF | BRAIN WATCH LTD. (IL) | 2007-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240652-A1 | ANTIBODIES AGAINST SEROTONIN, TRYPTOPHAN AND KYNURENINE METABOLITES AND USES THEREOF | TPH1, HTR5A, KYNU | USP2 3713/4885GAA 3364/4885ALOX15 329/4885 |
| US-20090005381-A1 | METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS | TPH1, TPH2, HNMT | USP2 2325/4885GAA 218/4885ALOX15 354/4885 |
| US-20090029993-A1 | METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN | TPH1, TPH2, HNMT | USP2 1877/4885GAA 445/4885ALOX15 552/4885 |
| US-20090005382-A1 | METHODS OF USING AND COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS | TPH1, TPH2, MAOB | USP2 935/4885GAA 369/4885ALOX15 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.